Basics Recursion Pharmaceuticals, Inc. IPO Date: April 16, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.78B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 3.94% Avg Daily Range (30 D): $0.16 | 3.26% Avg Daily Range (90 D): $0.29 | 4.49% Institutional Daily Volume Avg Daily Volume: 4.73M Avg Daily Volume (30 D): 17.45M Avg Daily Volume (90 D): 22.33M Trade Size Avg Trade Size (Sh.): 167 Avg Trade Size (Sh.) (30 D): 309 Avg Trade Size (Sh.) (90 D): 255 Institutional Trades Total Inst.Trades: 2,022 Avg Inst. Trade: $2.3M Avg Inst. Trade (30 D): $1.57M Avg Inst. Trade (90 D): $1.78M Avg Inst. Trade Volume: .26M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.72M Avg Closing Trade (30 D): $2.75M Avg Closing Trade (90 D): $4.19M Avg Closing Volume: 418.15K         News May 27, 2025 @ 12:05 AM 3 Monster Stocks to Hold for the Next 10 Years Source: James Brumley May 12, 2025 @ 8:18 AM Should You Buy This Beaten-Down Artificial Intelli... Source: Prosper Junior Bakiny May 9, 2025 @ 9:17 PM Why Recursion Pharmaceuticals Stock Plummeted 24% ... Source: Johnny Rice May 4, 2025 @ 4:45 PM Preliminary Phase 1b/2 Data for REC-4881 in Famili... Source: Recursion Apr 25, 2025 @ 9:10 PM Why Biohaven Stock Plummeted by More Than 15% Toda... Source: Eric Volkman Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.81 $-.5 $-.57 Diluted EPS $-1.81 $-.5 $-.57 Revenue $ 59.79M $ 14.75M $ 4.55M Gross Profit $ 3.89M $ -7.08M $ -8.25M Net Income / Loss $ -574.78M $ -202.49M $ -178.91M Operating Income / Loss $ -574.03M $ -191.37M $ -183.77M Cost of Revenue $ 55.9M $ 21.83M $ 12.79M Net Cash Flow $ 203.01M $ -93.87M $ 167.19M PE Ratio